Ebene Magazine – [Featured topics: Japanese stocks] JCR Pharmaceuticals — Significantly continued growth, viewing coverage of vaccine manufacturing plants as material (January 27, 2021) –Excite News

0
5
Ebene Magazine - [Featured topics: Japanese stocks] JCR Pharmaceuticals --- Significantly continued growth, viewing coverage of vaccine manufacturing plants as material (January 27, 2021) --Excite News

[Featured topics: Japanese stocks] JCR Pharmaceuticals — Significantly continued growth, European securities upgraded due to expectations for future event achievement

* 10: 17 JST JCR Pharmaceuticals — Significantly continued growth, European securities upgraded due to expectations for future event achievement JCR Pharma continued to grow significantly. Credit Suisse Securities ranks investment decisions from « neutral » to « outperform » …

[Featured topics: Japanese stocks] Nipro — Significantly continued growth, seeing news of increased production of « Dializer » as good news

* 11: 26 JST Nipro — Significantly continued growth, Nipro saw a significant increase in production of « Dializer » as good news. It is reported that the production of artificial kidneys for dialysis will be increased by investing more than 100 billion yen worldwide by FY2014. Vietnam and Japan …

[Emerging Market Snapshot] AnGes — Temporary Stop High, « Advance Clinical Trial of New Corona Vaccine » Report

* 12: 46 JST AnGes 905 147 Temporary stop height. It has hit a new high since the beginning of the year. Some media reports that they have decided to advance the clinical trial (clinical trial) of the new coronavirus vaccine, and it is being viewed as a buying material …

Related title :
[Featured topics Japanese stock] JCR Pharmaceuticals — Significantly continued growth, material view of coverage of vaccine manufacturing plant
JCR Pharmaceuticals is significantly higher and 4 days in a row, presence again as vaccine related
First coverage of domestic vaccine manufacturing plant
JCR Pharmaceuticals- Soaring Soaring interviews with the company’s contract vaccine manufacturing plant as material
JCR Pharma — Significantly continued growth, looking at coverage of vaccine manufacturing plant as material
[Original] Vaccine » Astra Zeneca « First interview with a stock solution manufacturing plant in Hyogo Prefecture
JCR Pharmaceuticals sees the production of a new corona vaccine stock solution for AstraZeneca as a material and reappears further

Ref: https://www.excite.co.jp

QU’EN PENSEZ-VOUS?

[comment]

Partners:

Journal D’Afrique (https://www.journaldafrique.com/)

Ebene News (https://www.ebenenews.com/)

Laisser un commentaire, votre avis compte!

[gs-fb-comments] [comment-form]